Dobutamine increases cardiac output of the total artificial heart. Implications for vascular contribution of inotropic agents to augmented ventricular function.
Authors:
- 1 September 1991
- journal article
- abstracts
- Published by Wolters Kluwer Health in Circulation
- Vol. 84 (3) , 1210-1215
Abstract
BACKGROUND: The synthetic catecholamine dobutamine increases stroke volume in normal subjects and in patients with congestive heart failure. In addition to its direct influence on myocardial contractility, dobutamine may significantly modulate vascular tone because of its alpha- and beta-adrenergic agonist activity. METHODS AND RESULTS: To test the hypothesis that such vasoactive properties significantly contribute to the improved ventricular performance noted with this agent, hemodynamic parameters were measured during stepped ascension infusion of dobutamine in a model that is insensitive to positive inotropic stimulation. Administration of dobutamine in nine calves that underwent replacement of the native right and left ventricles with pneumatically driven total artificial hearts resulted in a significant (p = 0.0001) increase in cardiac output from 7.0 +/- 1.8 to 8.2 +/- 1.8 l/min and a significant (p = 0.0001) decrease in total peripheral vascular resistance from 1,224 +/- 559 to 745 +/- 317 dyne.sec/cm5. A less marked influence was noted on the pulmonary vasculature, with pulmonary vascular resistance exhibiting a significant (p less than 0.05) decrease from its baseline value only at the peak infusion. Consistent with an increase in venous return, both left and right atrial pressures increased significantly (p less than 0.005) with dobutamine administration. CONCLUSIONS: These data demonstrate that the vasoactive properties of dobutamine significantly contribute to improved ventricular performance independent of direct myocardial stimulation. This effect appears to result in part from a direct modulation of myocardial stimulation. This effect appears to result in part from a direct modulation of arterial and venous tones rather than from a reflex response to primary changes in contractility.Keywords
This publication has 11 references indexed in Scilit:
- Effects of dopamine on left ventricular afterload and contractile state in heart failure: Relation to the activation of beta1-adrenoceptors and dopamine receptorsJACC, 1988
- Dopamine and Norepinephrine Increase Venous Return by Stimulating α and β Adrenoceptors in the DogJournal of Cardiovascular Pharmacology, 1988
- Regulation of Pneumatic Total Artificial Heart Function: A ReviewThe International Journal of Artificial Organs, 1988
- Evaluation of total artificial heart performance in manThe American Journal of Cardiology, 1984
- A Cardiac Output Monitor and Diagnostic Unit for Pneumatically Driven Artificial HeartsArtificial Organs, 1984
- Drugs Five Years LaterAnnals of Internal Medicine, 1983
- Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.Circulation, 1978
- Measurement of the circulatory effects of dobutamine, a new inotropic agent, in patients following cardiac surgeryAmerican Heart Journal, 1978
- Comparative systemic and regional hemodynamic effects of dopamine and dobutamineAmerican Heart Journal, 1975
- Effects of Dobutamine on Left Ventricular Performance, Coronary Dynamics, and Distribution of Cardiac Output in Conscious DogsJournal of Clinical Investigation, 1974